CoChat
Sign Up
Cited by 162Pancreatic and Hepatic Oncology ResearchMRI in cancer diagnosisMedical Imaging Techniques and Applications

The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.

Imaging diagnosis and staging of pancreatic ductal adenocarcinoma: a comprehensive review

Open access
Elbanna, Khaled Y., Jang, Hyun-Jung, Kim, Tae Kyoung·2020·Insights into Imaging
DOI 10.1186/s13244-020-00861-yPMC PMC7183518
Open this paper in CoChat — free accountOpen PDF

Abstract

Pancreatic ductal adenocarcinoma (PDAC) has continued to have a poor prognosis for the last few decades in spite of recent advances in different imaging modalities mainly due to difficulty in early diagnosis and aggressive biological behavior. Early PDAC can be missed on CT due to similar attenuation relative to the normal pancreas, small size, or hidden location in the uncinate process. Tumor resectability and its contingency on the vascular invasion most commonly assessed with multi-phasic thin-slice CT is a continuously changing concept, particularly in the era of frequent neoadjuvant therapy. Coexistent celiac artery stenosis may affect the surgical plan in patients undergoing pancreaticoduodenectomy. In this review, we discuss the challenges related to the imaging of PDAC. These include radiological and clinical subtleties of the tumor, evolving imaging criteria for tumor resectability, preoperative diagnosis of accompanying celiac artery stenosis, and post-neoadjuvant therapy imaging. For each category, the key imaging features and potential pitfalls on cross-sectional imaging will be discussed. Also, we will describe the imaging discriminators of potential mimickers of PDAC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13244-020-00861-y

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 A 72-year-old man with isoattenuating PDAC. Axial pancreatic phase CT image (a) shows MPD stricture (arrow) at the pancreatic body without visible mass. Transverse transabdominal ultrasound image (b) shows a hypoechoic mass (asterisk) at the site of MPD stricture (arrow). Dynamic contrast-enhanced MR images using fat-suppressed T1-weighted sequence in the arterial (c) and portal venous (d) phases show MPD stricture (arrow) but fail to demonstrate a distinct mass. Subsequent pancreaticoduodenectomy revealed PDAC
Fig. 1 A 72-year-old man with isoattenuating PDAC. Axial pancreatic phase CT image (a) shows MPD stricture (arrow) at the pancreatic body without visible mass. Transverse transabdominal ultrasound image (b) shows a hypoechoic mass (asterisk) at the site of MPD stricture (arrow). Dynamic contrast-enhanced MR images using fat-suppressed T1-weighted sequence in the arterial (c) and portal venous (d) phases show MPD stricture (arrow) but fail to demonstrate a distinct mass. Subsequent pancreaticoduodenectomy revealed PDACCC BY · PubMed Central
Fig. 2 A 72-year-old man with PDAC. Axial portal venous phase CT image (a) shows MPD stricture (arrow) at the pancreatic body with upstream dilatation without visible obstructing mass. Axial portal venous phase CT images (b and c) obtained 6 months later show the progression of the MPD stricture (arrow) with worsened upstream ductal dilatation and pancreatic atrophy. There is a small hypoattenuating mass (arrowheads in c) associated with an enlarged necrotic metastatic portacaval lymph node (asterisk)
Fig. 2 A 72-year-old man with PDAC. Axial portal venous phase CT image (a) shows MPD stricture (arrow) at the pancreatic body with upstream dilatation without visible obstructing mass. Axial portal venous phase CT images (b and c) obtained 6 months later show the progression of the MPD stricture (arrow) with worsened upstream ductal dilatation and pancreatic atrophy. There is a small hypoattenuating mass (arrowheads in c) associated with an enlarged necrotic metastatic portacaval lymph node (asterisk)CC BY · PubMed Central
Fig. 3 A 63-year-old man with locally advanced PDAC in uncinate process. Axial pancreatic phase CT images (a and b) show a mass (arrowhead) in the uncinate process encasing SMA with mild upstream dilatation of CBD (arrow) and MPD (short arrows) and associated with mildly distended gallbladder (GB)
Fig. 3 A 63-year-old man with locally advanced PDAC in uncinate process. Axial pancreatic phase CT images (a and b) show a mass (arrowhead) in the uncinate process encasing SMA with mild upstream dilatation of CBD (arrow) and MPD (short arrows) and associated with mildly distended gallbladder (GB)CC BY · PubMed Central
Fig. 4 A 63-year-old man with uncinate process PDAC causing a duodenal obstruction. Axial pancreatic phase CT images (a and b) show a hypoattenuating mass (asterisk) arising from the uncinate process, infiltrating the third part of the duodenum (D) and abutting the anterior wall of the aorta. CBD (arrow) is normal in caliber. The pancreas (P) has no ductal dilatation or atrophy. Axial portal venous phase CT image (c) obtained 1 month later shows a marked distension of the stomach (S) due to duodenal obstruction and there is a new hypoattenuating metastatic liver lesion (arrow)
Fig. 4 A 63-year-old man with uncinate process PDAC causing a duodenal obstruction. Axial pancreatic phase CT images (a and b) show a hypoattenuating mass (asterisk) arising from the uncinate process, infiltrating the third part of the duodenum (D) and abutting the anterior wall of the aorta. CBD (arrow) is normal in caliber. The pancreas (P) has no ductal dilatation or atrophy. Axial portal venous phase CT image (c) obtained 1 month later shows a marked distension of the stomach (S) due to duodenal obstruction and there is a new hypoattenuating metastatic liver lesion (arrow)CC BY · PubMed Central
Fig. 5 A 47-year-old man with uncinate process PDAC. Axial (a) and coronal (b) pancreatic phase CT images show a small hypoattenuating mass (arrowheads) in the uncinate process of the pancreas. Due to the location of the tumor, there is no CBD or MPD dilatation. EUS-guided biopsy revealed PDAC and the patient underwent pancreaticoduodenectomy
Fig. 5 A 47-year-old man with uncinate process PDAC. Axial (a) and coronal (b) pancreatic phase CT images show a small hypoattenuating mass (arrowheads) in the uncinate process of the pancreas. Due to the location of the tumor, there is no CBD or MPD dilatation. EUS-guided biopsy revealed PDAC and the patient underwent pancreaticoduodenectomyCC BY · PubMed Central
Fig. 6 A 63-year-old man with PDAC. Axial pancreatic phase CT images (a and b) show a hypoattenuating mass (asterisk) in the pancreatic head with > 180° tumor contact with a replaced right hepatic artery (long arrow) and > 180° tumor contact with SMV (short arrow) with deformity of the vein lumen. The patient underwent a total pancreatectomy and vascular reconstruction after neoadjuvant therapy, but liver metastases developed one year after surgery
Fig. 6 A 63-year-old man with PDAC. Axial pancreatic phase CT images (a and b) show a hypoattenuating mass (asterisk) in the pancreatic head with > 180° tumor contact with a replaced right hepatic artery (long arrow) and > 180° tumor contact with SMV (short arrow) with deformity of the vein lumen. The patient underwent a total pancreatectomy and vascular reconstruction after neoadjuvant therapy, but liver metastases developed one year after surgeryCC BY · PubMed Central
Fig. 7 A 64-year-old man with PDAC of the head. Coronal T2-weighted MR image (a) shows a large low-intermdiate signal intensity pancreatic head mass (asterisk) causing upstream CBD dilatation (long arrow). Axial contrast-enhanced T1-weighted image in the portal venous phase (b) shows a hypoenhancing pancreatic head mass abutting SMV. Coronal (c) and axial (d) portal venous phase CT images obtained 2 months later after neoadjuvant therapy show a significant reduction of the tumor bulk (short arrows). The patient subsequently underwent pancreaticoduodenectomy, and pathology revealed extensive neoadjuvant treatment effect on PDAC with only 1 cm residual tumor and negative resection margin. No recurrence has been reported for 3 years
Fig. 7 A 64-year-old man with PDAC of the head. Coronal T2-weighted MR image (a) shows a large low-intermdiate signal intensity pancreatic head mass (asterisk) causing upstream CBD dilatation (long arrow). Axial contrast-enhanced T1-weighted image in the portal venous phase (b) shows a hypoenhancing pancreatic head mass abutting SMV. Coronal (c) and axial (d) portal venous phase CT images obtained 2 months later after neoadjuvant therapy show a significant reduction of the tumor bulk (short arrows). The patient subsequently underwent pancreaticoduodenectomy, and pathology revealed extensive neoadjuvant treatment effect on PDAC with only 1 cm residual tumor and negative resection margin. No recurrence has been reported for 3 yearsCC BY · PubMed Central
Fig. 8 A 62-year-old woman with PDAC of the head. Axial portal venous phase CT images (a and b) show an ill-defined hypoattenuating mass encasing SMA (long arrow). SMV demonstrates a teardrop sign (short arrow) and is completely obliterated at a higher level (not shown). Axial portal venous phase CT images (c and d) obtained 2 months after neoadjuvant therapy show interval reduction of the tumor size and tumor contact with SMA (long arrow) and SMV (short arrow). The patient underwent pancreaticoduodenectomy and pathology revealed no residual invasion to SMA
Fig. 8 A 62-year-old woman with PDAC of the head. Axial portal venous phase CT images (a and b) show an ill-defined hypoattenuating mass encasing SMA (long arrow). SMV demonstrates a teardrop sign (short arrow) and is completely obliterated at a higher level (not shown). Axial portal venous phase CT images (c and d) obtained 2 months after neoadjuvant therapy show interval reduction of the tumor size and tumor contact with SMA (long arrow) and SMV (short arrow). The patient underwent pancreaticoduodenectomy and pathology revealed no residual invasion to SMACC BY · PubMed Central
Fig. 9 A 60-year-old man undergoing preoperative imaging for PDAC. Axial (a and b), and sagittal (c) pancreatic phase CT images show ostial stenosis of the celiac artery (arrow) due to atherosclerotic disease. The patient has a biliary stent (curved arrow) and PDAC is identified as a subtle hypoattenuating lesion (arrowheads). Axial fat-suppressed T1-weighted MR image (d) clearly demonstrates PDAC as a hypointense mass. Intraoperative Doppler ultrasound (e and f) shows a significant celiac artery stenosis by demonstrating caudocranial/reversed blood flow in the gastroduodenal artery, denoting its significant contribution to the hepatic arterial supply. The patient subsequently underwent pancreaticoduodenectomy after celiac artery stenting
Fig. 9 A 60-year-old man undergoing preoperative imaging for PDAC. Axial (a and b), and sagittal (c) pancreatic phase CT images show ostial stenosis of the celiac artery (arrow) due to atherosclerotic disease. The patient has a biliary stent (curved arrow) and PDAC is identified as a subtle hypoattenuating lesion (arrowheads). Axial fat-suppressed T1-weighted MR image (d) clearly demonstrates PDAC as a hypointense mass. Intraoperative Doppler ultrasound (e and f) shows a significant celiac artery stenosis by demonstrating caudocranial/reversed blood flow in the gastroduodenal artery, denoting its significant contribution to the hepatic arterial supply. The patient subsequently underwent pancreaticoduodenectomy after celiac artery stentingCC BY · PubMed Central
Fig. 10 A 71-year-old man with a mass-forming AIP. Axial (a–c) pancreatic phase CT images show two ill-defined, mass-like lesions (asterisk) in the pancreatic body without significant MPD dilatation (arrows). There is associated rind of periaortic soft tissue thickening (arrowheads) representing IgG4-related retroperitoneal fibrosis
Fig. 10 A 71-year-old man with a mass-forming AIP. Axial (a–c) pancreatic phase CT images show two ill-defined, mass-like lesions (asterisk) in the pancreatic body without significant MPD dilatation (arrows). There is associated rind of periaortic soft tissue thickening (arrowheads) representing IgG4-related retroperitoneal fibrosisCC BY · PubMed Central
Fig. 11 A 60-year-old woman with a segmental form of groove pancreatitis. Coronal portal venous phase CT image (a) shows a hypoattenuating sheet-like area in the pancreaticoduodenal groove (between long arrows) associated with mural thickening and luminal narrowing of the descending duodenum. CBD (short arrow) is displaced medially by the inflammatory process and tapers distally. MR images with coronal T2 HASTE sequence (b), axial fat-suppressed T1 sequence (c), and axial contrast-enhanced fat-suppressed T1 sequence of the delayed phase (d) show the pancreaticoduodenal groove abnormality (between long arrows) containing multiple tiny cysts along the duodenal wall with high T2-signal intensity and a sheet of fibro-inflammatory tissue with low T1-signal intensity, and delayed enhancement. Non-enhancing tiny pseuodocyst is noted (curved arrow). CBD (short arrow) and MPD (arrowhead) are not dilated. The patient has improved on subsequent follow-up
Fig. 11 A 60-year-old woman with a segmental form of groove pancreatitis. Coronal portal venous phase CT image (a) shows a hypoattenuating sheet-like area in the pancreaticoduodenal groove (between long arrows) associated with mural thickening and luminal narrowing of the descending duodenum. CBD (short arrow) is displaced medially by the inflammatory process and tapers distally. MR images with coronal T2 HASTE sequence (b), axial fat-suppressed T1 sequence (c), and axial contrast-enhanced fat-suppressed T1 sequence of the delayed phase (d) show the pancreaticoduodenal groove abnormality (between long arrows) containing multiple tiny cysts along the duodenal wall with high T2-signal intensity and a sheet of fibro-inflammatory tissue with low T1-signal intensity, and delayed enhancement. Non-enhancing tiny pseuodocyst is noted (curved arrow). CBD (short arrow) and MPD (arrowhead) are not dilated. The patient has improved on subsequent follow-upCC BY · PubMed Central
Fig. 12 A 39-year-old woman with focal fat infiltration of the pancreatic head. Axial portal venous phase CT image (a) show low-attenuation area (arrows) in the pancreatic head with a tongue-like extension just posterior to SMV. No mass effect or MPD dilatation. Note the normal attenuation parenchyma around the CBD. Axial chemical shift MR images show no abnormality at in-phase sequence (b) and drop of signal of the same area (arrows) at opposed phase sequence (c) consistent of microscopic fat in focal fat infiltration
Fig. 12 A 39-year-old woman with focal fat infiltration of the pancreatic head. Axial portal venous phase CT image (a) show low-attenuation area (arrows) in the pancreatic head with a tongue-like extension just posterior to SMV. No mass effect or MPD dilatation. Note the normal attenuation parenchyma around the CBD. Axial chemical shift MR images show no abnormality at in-phase sequence (b) and drop of signal of the same area (arrows) at opposed phase sequence (c) consistent of microscopic fat in focal fat infiltrationCC BY · PubMed Central
Fig. 13 A 53-year-old man with a pancreatic neuroendocrine tumor of the head. Axial arterial phase (a) and portal venous phase (b) and (c) CT images show a well-defined mass (asterisk) with peripheral hypervascularity and central cystic area. Only mild dilatation of the MPD (arrow) due to external compression by the tumor, rather than ductal origin of the tumor. Histopathology revealed pancreatic endocrine tumor
Fig. 13 A 53-year-old man with a pancreatic neuroendocrine tumor of the head. Axial arterial phase (a) and portal venous phase (b) and (c) CT images show a well-defined mass (asterisk) with peripheral hypervascularity and central cystic area. Only mild dilatation of the MPD (arrow) due to external compression by the tumor, rather than ductal origin of the tumor. Histopathology revealed pancreatic endocrine tumorCC BY · PubMed Central
Fig. 14 A 72-year-old man with papillary thyroid cancer metastasis involving the pancreas. Axial pancreatic phase CT image shows multiple enhancing masses (asterisks) involving the entire pancreas
Fig. 14 A 72-year-old man with papillary thyroid cancer metastasis involving the pancreas. Axial pancreatic phase CT image shows multiple enhancing masses (asterisks) involving the entire pancreasCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 103 references

Cited by

Sorted by citations

See all 162

Related

Metadata

Authors
Elbanna, K. Y., Jang, H.-J., & Kim, T. K.
Affiliations
Mount Sinai Hospital (CA)
Corresponding author
Elbanna, Khaled Y.
ORCID
Venue
Insights into Imaging
Publisher
Springer Science and Business Media LLC
Published
2020-04-25
Volume
11
Issue
1
Pages
58-58
ISSN
1869-4101 (ISSN-L)
DOI
10.1186/s13244-020-00861-y
PMC
PMC7183518
OpenAlex
W3020216905
Semantic Scholar
39a22c3369f8e93fba45dd757563476bc863f51e
Cited by
162
References
103
Citations by year
2026: 28 · 2025: 31 · 2024: 29 · 2023: 28 · 2022: 21 · 2021: 22 · 2020: 2
FWCI
1.96
Type
journal article
Language
en
Open access
Licence
Locations
  • Insights into Imaging (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • TSpace (University of Toronto) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Keywords
pancreatic ductal adenocarcinoma, tumor resectability, celiac artery stenosis, pancreaticoduodenectomy, neoadjuvant therapy, tumor staging, early diagnosis, vascular invasion, uncinate process

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review